Insider · CIK 0001556583
David Hrinak
Files at CAPL (CrossAmerica Partners LP). First filing -, latest -.
David Hrinak files SEC Form 4 as officer at CAPL (CrossAmerica Partners LP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David Hrinak has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | CAPL CrossAmerica Partners LP | AGrant or award Common Units | +1,832 | - | - | 51,331 | Feb 25, 2026 |
| Feb 24, 2026 | CAPL CrossAmerica Partners LP | FTax withholding Common Units | -624 | $20.78 | $13k | 50,707 | Feb 25, 2026 |
| Feb 25, 2025 | CAPL CrossAmerica Partners LP | AGrant or award Common Units | +1,167 | - | - | 49,897 | Feb 27, 2025 |
| Feb 25, 2025 | CAPL CrossAmerica Partners LP | FTax withholding Common Units | -398 | $22.80 | $9,074 | 49,499 | Feb 27, 2025 |
Questions about David Hrinak
Answered from the filings on this page, as of the latest one.
Is David Hrinak buying or selling?
David Hrinak has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David Hrinak's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Hrinak has 0.
Where does David Hrinak file Form 4?
David Hrinak has filed Form 4 at CAPL (CrossAmerica Partners LP) as Executive Vice President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.